Suchergebnisse
-
Anna-Lena Engwall - Global Commercial Vice President & Franchise Head Cardiovascular & Renal, Metabolic - hält ein Bachelor of Science in Nursing der Karolinska Institute.AstraZeneca - Pharmazie - Großbritannien
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Alligator Bioscience - Biotechnologie - Schweden
-
Yilmaz Mahshid - Director - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Malene Jensen - Vice President, Clinical Development - has a PhD in Clinical Neuroscience from Karolinska Institute and Master of Science in Molecular Biology from Stockholm University.Pia Baumann - Chief Medical Officer - hält ein PhD in Oncology der Karolinska Institute.Medivir - Biotechnologie - Schweden
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Anocca - Biotechnologie - Schweden
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Arrakis Therapeutics - Biotechnologie - USA
-
Per Lundin - Chief Executive Officer and Director - has a PhD in Medical Science from Karolinska Institute and Licentiate in Neurochemistry from Stockholm University.Evox Therapeutics - Biotechnologie - Großbritannien
-
Anders Ekblom - Non-Executive Director - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Mereo BioPharma - Pharmazie - Großbritannien
-
Roger Tell - Director - has a Phd, Experimental Oncology from Karolinska Institute and Medical Doctorate from Karolinska Institute.Vivesto - Gesundheitswesen - Schweden
-
Jakob Loven - Board Member - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.IconOVir Bio - Biotechnologie - USA
-
Jan Lundberg - Independent Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Metabolon - Biotechnologie - USA
-
Yilmaz Mahshid - Chief Financial Officer - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Desiree Luthman - Vice President, Global Regulatory Affairs - hält ein Doctor of Dental Surgery der Karolinska Institute.Egetis Therapeutics - Biotechnologie - Schweden
-
Per Grufman - Chief Executive Officer, Biocrucible - has a PhD in Immunology from Karolinska Institute and Master of Science in biology from Stockholm University.Sapphiros - Biotechnologie - USA
-
Hans Basun - Senior Director Clinical Development - hält ein Medical Doctorate der Karolinska Institute.Anna-Lena Engwall - Director - hält ein Bachelor of Science in Nursing der Karolinska Institute.BioArctic - Biotechnologie - Schweden
-
Per Grufman - Chief Executive Officer - has a PhD in Immunology from Karolinska Institute and Master of Science in biology from Stockholm University.Biocrucible - Biotechnologie - Großbritannien
-
Johan Lof - Founder, Chief Executive Officer, President and Director - has a PhD from Karolinska Institute and Master of Science in Engineering from Royal Institute of Technology.Raysearch Laboratories - Umweltdienste - Schweden
-
Claes Lindh - Chief Medical Officer - hält ein PhD in Prostate Cancer Pathology der Karolinska Institute.Inify Laboratories - Biotechnologie - Schweden
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Hexagon Bio - Biotechnologie - USA
-
Jarl Jungnelius - Board Member - hält ein Doctor of Medicine der Karolinska Institute.Oncopeptides - Biotechnologie - Schweden